No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PFE240726C27500
- 2.40
- 0.000.00%
15min DelayClose Jul 19 16:00 ET
2.53High2.35Low
2.40Open2.40Pre Close20 Volume180 Open Interest27.50Strike Price4.80KTurnover63.93%IV-0.23%PremiumJul 26, 2024Expiry Date2.47Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8892Delta0.0863Gamma11.48Leverage Ratio-0.0457Theta0.0031Rho10.21Eff Leverage0.0065Vega
Intraday
- 5D
- Daily
News
Better Dark Horse Weight Loss Drug Stock: Pfizer Vs. Roche
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Here Are Big Pharma's Leading Blockbuster Makers
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Pfizer Options Spot-On: On July 19th, 130.08K Contracts Were Traded, With 3 Million Open Interest
On July 19th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 130.08K options for the day, of which put options accounted for 32.41% of the total transactions, and
Check Out What Whales Are Doing With PFE
Investors with a lot of money to spend have taken a bullish stance on Pfizer (NYSE:PFE).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Comments
$Pfizer(PFE.US$ this is the only healthcare share rise today . what’s happening to others
“History Doesn’t Repeat Itself, but It Often Rhymes” – Mark Twain
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US$ $iShares Russell 2000 ETF(IWM.US$ $MarketAxess(MKTX.US$ $Pfizer(PFE.US$ $Vanguard Real Estate ETF(VNQ.US$ $Global Payments(GPN.US$
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US$ $iShares Russell 2000 ETF(IWM.US$ $MarketAxess(MKTX.US$ $Pfizer(PFE.US$ $Vanguard Real Estate ETF(VNQ.US$ $Global Payments(GPN.US$
loading...
4
Why do you think $Pfizer(PFE.US$ decided to progress with Danuglipron? (![]()
Can't give up this huge market?
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US$ Orforglipron and $Structure Therapeutics(GPCR.US$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
+1
5
Read more